Cargando…

Resveratrol raises in vitro anticancer effects of paclitaxel in NSCLC cell line A549 through COX-2 expression

The aim of this study was to determine the raising anticancer effects of resveratrol (Res) on paclitaxel (PA) in non-small cell lung cancer (NSCLC) cell line A549. The 10 µg/ml of Res had no effect on human fetal lung fibroblast MRC-5 cells or on A549 cancer cells and the 5 or 10 µg/ml of PA also ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Fanhua, Zhang, Runqi, Zhao, Xudong, Zheng, Guanlin, Wang, Zhou, Wang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Physiological Society and The Korean Society of Pharmacology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587597/ https://www.ncbi.nlm.nih.gov/pubmed/28883751 http://dx.doi.org/10.4196/kjpp.2017.21.5.465

Ejemplares similares

Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2
por: Li, Xia, et al.
Publicado: (2018)

Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells
por: Jiang, Qin, et al.
Publicado: (2017)

Anticancer Properties of Fluorinated Aminophenylhydrazines on A549 Lung Carcinoma Cell Line
por: SAK, Zafer Hasan Ali, et al.
Publicado: (2021)

Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer A549 cells in vitro
por: Liu, Yanguo, et al.
Publicado: (2021)

miR-101 sensitizes A549 NSCLC cell line to CDDP by activating caspase 3-dependent apoptosis
por: YIN, JIQING, et al.
Publicado: (2014)

Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
por: Hattar, Katja, et al.
Publicado: (2012)

Jiegeng Decoction Potentiates the Anticancer Efficacy of Paclitaxel in vivo and in vitro
por: Chen, Haifang, et al.
Publicado: (2022)

Altered Mitochondrial Dynamics, Biogenesis, and Functions in the Paclitaxel-Resistant Lung Adenocarcinoma Cell Line A549/Taxol
por: Zhou, Xiang, et al.
Publicado: (2020)

Curcumin induced autophagy anticancer effects on human lung adenocarcinoma cell line A549
por: Liu, Furong, et al.
Publicado: (2017)

Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549()
por: Tièche, Colin Charles, et al.
Publicado: (2018)

Anticancer Molecular Mechanisms of Resveratrol
por: Varoni, Elena M., et al.
Publicado: (2016)

In vitro studies data on anticancer activity of Caesalpinia sappan L. heartwood and leaf extracts on MCF7 and A549 cell lines
por: Naik Bukke, Arunkumar, et al.
Publicado: (2018)

Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells
por: Momchilova, Albena, et al.
Publicado: (2022)

Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way
por: Xie, Jun, et al.
Publicado: (2016)

Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines
por: Rabzia, Arezou, et al.
Publicado: (2017)

Promising Anticancer Effect of Aurisin A Against the Human Lung Cancer A549 Cell Line
por: Boueroy, Parichart, et al.
Publicado: (2020)

Anticancer activity of Caesalpinia sappan by downregulating mitochondrial genes in A549 lung cancer cell line
por: Widodo, Nashi, et al.
Publicado: (2022)

RETRACTED ARTICLE: Effect of Paclitaxel-Mesoporous Silica Nanoparticles with a Core-Shell Structure on the Human Lung Cancer Cell Line A549
por: Wang, Tieliang, et al.
Publicado: (2017)

Retraction Note to: Effect of Paclitaxel-Mesoporous Silica Nanoparticles with a Core-Shell Structure on the Human Lung Cancer Cell Line A549
por: Wang, Tieliang, et al.
Publicado: (2022)

Interleukin-1β weakens paclitaxel sensitivity through regulating autophagy in the non-small cell lung cancer cell line A549
por: Lian, Juanwen, et al.
Publicado: (2021)

Unraveling the Anticancer Effect of Curcumin and Resveratrol
por: Pavan, Aline Renata, et al.
Publicado: (2016)

Nab-paclitaxel as First Line Treatment for NSCLC in Elderly Patients More Than 75 Years Old
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes
por: Barani, Mahmood, et al.
Publicado: (2021)

Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms
por: Maurya, Dharmendra K., et al.
Publicado: (2011)

Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer
por: Wang, Siwan, et al.
Publicado: (2021)

Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3
por: Kim, Hee Jung, et al.
Publicado: (2014)

Resveratrol treatment inhibits acute pharyngitis in the mice model through inhibition of PGE2/COX-2 expression
por: Yu, Zhaoyan, et al.
Publicado: (2018)

Effects of Ceragenins and Antimicrobial Peptides on the A549 Cell Line and an In Vitro Co-Culture Model of A549 Cells and Pseudomonas aeruginosa
por: Oyardi, Ozlem, et al.
Publicado: (2022)

The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China
por: Xing, Puyuan, et al.
Publicado: (2017)

Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1
por: Cheng, Ruirui, et al.
Publicado: (2022)

Differences in Fatty Acid Oxidation between Nab-Paclitaxel- and Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics
por: Huang, Jhih-Wei, et al.
Publicado: (2021)

Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues
por: Ferraz da Costa, Danielly C., et al.
Publicado: (2020)

Biosynthesis of ZnONP Using Chamaecostus cuspidatus and Their Evolution of Anticancer Property in MCF-7 and A549 Cell Lines
por: Balaji, Menaka Priya, et al.
Publicado: (2022)

Bellidifolin Inhibits Proliferation of A549 Cells by Regulating STAT3/COX-2 Expression and Protein Activity
por: Yan, Li, et al.
Publicado: (2020)

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
por: Blais, Normand, et al.
Publicado: (2014)

Developing a CoMSIA Model for Inhibition of COX-2 by Resveratrol Derivatives
por: Shamsara, Jamal, et al.
Publicado: (2016)

Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line
por: Butcher, Kate, et al.
Publicado: (2018)

Clinically Relevant Anticancer Polymer Paclitaxel Therapeutics
por: Yang, Danbo, et al.
Publicado: (2010)

AQP3 Increases Intercellular Cohesion in NSCLC A549 Cell Spheroids through Exploratory Cell Protrusions
por: Min, Sol, et al.
Publicado: (2021)

Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
por: Mohsin, Noor ul Amin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6c8inak5ag3b58933vt5q7ebl2